Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance on Safety and Effectiveness Evaluation of INVOSSA K Inj.

NCT03412864 is registered in ClinicalTrials.gov with Kolon Life Science as lead sponsor.

NCT NCT03412864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03412864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance on Safety and Effectiveness Evaluation of INVOSSA K Inj.
Lead sponsor
Kolon Life Science
Phase
Observational
Overall status
Unknown status
Start date
July 12, 2017
Completion date
July 11, 2023
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis